ABOUT MAC
OUR ETHOS
The Montalcino Aortic Consortium (MAC) formed in 2013 around the need for international cooperation in the study of human diseases, largely determined by variation in genes, that affect the aorta and its major branches.
The goals are:
To improve the diagnostic criteria of a growing list of conditions, now more than two dozen
To understand the natural and clinical histories of these conditions
To discover additional genetic variations that predispose to aortopathy
To discover and test new approaches to treatment
And to facilitate collaborations in all of these endeavors
3rd MAC Summit, Borgo San Luigi, Monteriggioni (SI), Italy, April 28 – May 2, 2022
After several cancellations due to the COVID-19 pandemic and re-consideration, GADA Canada and the MAC …
4th MAC Summit, May 21 – 25, 2025 Monterrigioni (SI), Italy. Attendance by Invitation Only
GADA Canada and the MAC Executive Committee are excited to plan the 4th Montalcino Aortic Consortium Summit in Italy!
This Summit is organized and hosted by GADA Canada and made possible with funding from the Temerty Foundation and kind courtesy of Ludmilla Temertey.